Peritoneal Dialysis Region: Nephmadness 2018

This region explores the data available on the impact of volume overload and solute clearance on peritoneal dialysis (PD). In addition, we discuss the diagnosis and treatment of two common PD-related issues: culture-negative peritonitis and catheter dysfunction.

Check out the full NephMadness Peritoneal Dialysis Region here

Target Audience

  • Physicians
METHOD OF PARTICIPATION:
  • Read the educational summary for the Peritoneal Dialysis Region here
  • Make sure you completed a bracket with your predictions of what concepts are the most important or most impactful here
  • Participate in social media (Twitter, Instagram, Facebook, blogs) discussions about these concepts, sharing your opinions of what is the most important or impactful to you in nephrology.  
  • Login or create an account to this site and complete the evaluations and download certificate.

Learning Objectives

After participation in this activity, learners will be able to:

  • Distinguish the causes of common volume and solute issues related to peritoneal dialysis and understand how to modify the prescription  
  • Identify the common infectious etiologies of peritonitis, and how to manage culture negative peritonitis
  • Describe the common reasons for peritoneal catheter dysfunction and how to manage this problem clinically
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
Course opens: 
03/15/2018
Course expires: 
06/15/2018
Cost:
$0.00
Parent activity set: 
Rating: 
0

Amit Langote, MD, DNB 
Nephrologist
Apollo Hospital 
Navi Mumbai, Maharashtra India   
Disclosure: Has no financial relationships with commercial interest(s).  

Planning Committee Disclosures

Anna Burgner, MD, MEHP
Assistant Professor 
Vanderbilt Medical Center
Nashville, TN 
Disclosure: Primary Investigator: Bayer (Diabetic Nephropathy); inRegen (Diabetic Nephropath); AstraZeneca (CKD); Fibrogen (Anemia).

Thomas Golper, MD
Professor of Medicine
Vanderbilt University Medical Center
Nashville, TN 
Disclosure: Consulting: Keryx (ESRD). 

Danielle Nathan, MA
Professional Education Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Coordinator
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

DECLARATION OF DISCLOSURE:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

UNLABELED/INVESTIGATIONAL USE:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

The National Kidney Foundation is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.


 

Physician

The National Kidney Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

Accreditation Period

Course opens: 
03/15/2018
Course expires: 
06/15/2018

Price

Cost:
$0.00
Please login or register for a PERC account to take this course.
DISCLAIMER:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.